Key Points Oncolytics has secured a new patent in several countries covering pelareorep’s use as a cancer immunotherapy, with a corresponding U.S. patent expected soon….
October 13, 2026
September 17, 2026
Aethlon Medical Merges With North Immunology to Advance NOR-101 for Atopic Dermatitis
Key Points Aethlon Medical will merge with privately held North Immunology in an all-stock transaction. The combined company will operate as North Immunology, Inc. and is expected…
Aethlon Medical, Inc. (NASDAQ: AEMD) has announced new peer‑reviewed research supporting a mechanistic link between a novel long COVID biomarker and its Hemopurifier device, suggesting…
Biogen Inc. (Nasdaq: BIIB) is sharpening its immunology focus with an agreement to acquire privately held RayThera Inc., in a deal worth up to $1…